Suzhou Lixin Pharmaceutical Co., Ltd.

Company Description

Suzhou Lixin Pharmaceutical Co., Ltd. specializes in active pharmaceutical ingredients (APIs) and high-added-value intermediates. Suzhou Lixin Pharmaceutical Co., Ltd. has built workshops in accordance with GMP certification, chemical synthesis workshops, and other facilities, and established a standard quality management system and advanced quality control profile.

Oriented to the international market of APIs and intermediate materials, Lixin has built up strong cooperative relationships with domestic and international pharmaceutical companies. We have already developed series of APIs including anti-neoplastic medicines, cardiovascular medicines and other related products. In order to obtain favorable comments from customers for our high quality products and standard quality management system, Lixin insists on improving process and product quality under the guidelines of ICH and the rules of SFDA.

As a professional API manufacturer, Suzhou Lixin Pharmaceutical Co., Ltd. has a group of chemical scientists and managers engaged in the pharmaceutical industry for decades. They strive to make innovations in new product research and development, technological reform, quality control, quality management, and product sale and service, as well as many other aspects.

Our featured products include: Hydrochlorothiazide( GMP,DMF), Indapamide( GMP), Idebenone( GMP), Dacarbazine( GMP), Clopidogrel Bisulfate and Intermediates, Ritalin intermediates ( FDA Certificated).

Company Information

  • Contact Person:Ms. Li Yan
  • Department:Marketing
  • Telephone:
  • Fax:
  • Zip:215151
  • Province/State:Jiangsu
  • City:suzhou
  • Operational Address:No. 21, Tangxi Road, New Zone, Suzhou, Jiangsu, China (Mainland)
  • Business Type:Manufacturer, Trading Company
  • Year Established:1980
  • Number Of Employees:101 - 200 People
  • Total Revenue:US$10 Million - US$50 Million
  • Trade Capacity:Western Europe : 11.11% Eastern Asia : 11.11%
  • Production Capacity:- -
  • R&D Capacity:Equipment and Facilities :Agilent LC-MS.,Biotage m
  • Main Products:Hydrochlorothiazide,Idebenone,Indapamide,Oxaliplatin,Dacarbazine, Antimicrobial Agents,Anti-platelet Agent, Antineoplastic Agent, Cardiovascular Medicine, Intermediats, Antihyperlipidemic Agent, Pharmaceutic Adjuvant, Histamine H1 Antagonists, Cardiovascular Agents, Drugs For Senile Dementia, Tocolytic Agents,
  • Address:No.21,tangxi road,suzhou new district, jiangsu, china
  • Main Markets:Western Europe, Eastern Asia, Mid East, Oceania, A
  • Location:Jiangsu, China (Mainland)
  • Website:Visit website

Product

  • clopidogrel bisulfate
  • pharma raw materials
  • active pharmaceutical ingredients
  • (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide)
  • alpha-Phenylpiperidine-2-acetamide
  • Phenyl(2-piperidinyl)acetic acid;
  • Intermediate of pemetrexed
  • CLOPIDOGREL HYDROCHLORIDE
  • Clopidogrel besylate
  • Clopidogrel methanesulfonate
  • Clopidogrel camphorsulfonate
  • D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochl...
  • custom synthesis
  • Fasudil hydrochloride
  • Capecitabine intermediate 3
  • Capecitabine intermediate 2,3-di-O-acetyl-5-deoxy-5-Fluorocytidine
  • 1,2,3-tri-O-acetyl-5-deoxy-D-ribofuranose
  • pemetrexed intermeidate (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro...
  • Pemetrexed acid (intermeidate 1)
  • HYDROCHLOROTHIAZIDE
  • Idebenone
  • Indapamide
  • Dacarbazine
  • Pitavastatin calcium
  • Oxaliplatin
  • Hydrochlorothiazide
  • Bumetanide
  • Clopidogrel Bisulfate
  • Donepezil Hydrochloride
  • Ritodrine Hydrochloride
  • Chlorothiazide
  • Pemetrexed disodium
  • acrivastine
  • Cellulose Acetate Phthalate
  • alpha-Phenylpiperidine-2-acetic acid
  • 6-(10-Hydroxydecanoyl)-2,3-Dimethoxy-5-Methylphenol
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries